ImpediMed Limited (IPD) Q3 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Thank you for standing by and welcome to the ImpediMed Limited Investor Call Q3 FY25 results. All participants are in a listen-only mode. There will be a presentation followed by a question and answer session. If you wish to ask a question, you will need to press the star key followed by the number one on your telephone keypad. I would now like to hand the conference over to Ms. Palmjot Bain, CEO and Managing Director. Please go ahead. Thank you. Good morning and thank you for joining us to discuss our Q3 FY25 results. I'm pleased to be here with McGregor Grant, our CFO and COO. We'll be referencing the 4C quarterly activity report and presentation we lodged this morning with the ASX. The presentation is a summary of the more detailed 4C. After our remarks, we'll take questions. It's been another busy year with more progress and more change as we continue to refine and execute on our strategy. This week, I'm in the U.S. to attend the American Society of Breast Cancer Surgeon Conference, which begins later this week. It's a great opportunity to meet with a large number of customers and potential customers. And it's also a fantastic time to get the entire U.S. sales team together under our new SVP of sales, Scott Long. It's also a great opportunity. I'm excited to be joining the team here again this year. Now let's move into the presentation, and we'll begin with page three with a quick overview of the agenda for today's call. Consistent with previous quarters, we'll start today with a brief strategy recap. Then we'll cover the key highlights for quarter three. We'll take you through an overview of the business. McGregor will go through the financials. And to finish, we'll cover the outlook for the next quarter before commencing with a Q&A session. Now turning to page ...